Benitec Biopharma (BNTC) Announces 1:17 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil rises as renewed US-Iran strikes stoke supply fears
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
July 25, 2023 1:00 PM EDTHAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (Benitec or Company), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (ddRNAi)
Silence and Replace platform, announced today that it will effect a 1-for-17 reverse stock split (Reverse Stock Split) of its common stock, par value $0.0001 per share (Common Stock), that will become effective on July 26, 2023, at 12:01 a.m., Eastern Time. Benitecs Common Stock will continue to trade on The Nasdaq Capital Market (Nasdaq) under the existing symbol BNTC and will begin trading on a split-adjusted basis... More
